Review of Pediatric Attention Deficit/Hyperactivity Disorder for the General Psychiatrist

Psychiatric Clinics of North America

Volumn 32, Issue 1, 2009, Pages 39-56

  Kratochvil, Christopher J ^a   Vaughan, Brigette S ^a   Barker, Amy ^b   Corr, Lindsey ^b   Wheeler, Ashley ^b   Madaan, Vishal ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY   (United States)

Author keywords

ADHD; Attention; Diagnosis; Hyperactivity; Impulsivity; Treatment

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; CLONIDINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; GUANFACINE; LISDEXAMFETAMINE; METHYLPHENIDATE;

ANOREXIA; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; COMORBIDITY; DECREASED APPETITE; DIFFERENTIAL DIAGNOSIS; DRUG CHOICE; FAMILY; HEADACHE; HUMAN; IMPULSIVENESS; INSOMNIA; IRRITABILITY; LIVER DYSFUNCTION; MENTAL INSTABILITY; NAUSEA; OFF LABEL DRUG USE; ORTHOSTATIC HYPOTENSION; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHIATRIST; RECOMMENDED DRUG DOSE; REVIEW; SEDATION; SIDE EFFECT; SUICIDAL IDEATION; VOMITING;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PSYCHIATRY;

EID: 60549112550     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2008.10.001     Document Type: Review

References (66)

1. American Psychiatric Association: diagnostic and statistical manual of mental disorders fourth edition text revision (2000), American Psychiatric Association, Washington, DC
2. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States. MMWR Morb Mortal Wkly Rep 54 842 (2003) 842-847
3. Woodruff T.J., Axelrad D.A., Kyle A.D., et al. Trends in environmentally related childhood illnesses. Pediatrics 113 (2004) 1133-1140
4. Barkley R.A., Fischer M., Edelbrock C.S., et al. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 29 (1990) 546-547
5. Barkley R.A., Fischer M., Smallish L., et al. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 111 (2002) 279-289
6. Biederman J., Faraone S., Milberger S., et al. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 53 (1996) 437-446
7. Kessler R.C., Adler L.A., Barkley R., et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 57 (2005) 1442-1451
8. Lavigne J.V., Gibbons R.D., Christoffel K.K., et al. Prevalence rates and correlates of psychiatric disorders among preschool children. J Am Acad Child Adolesc Psychiatry 35 (1996) 204-214
9. Angold A., Erkanli A., Egger H.L., et al. Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry 39 (2000) 975-984
10. Biederman J., Kwon A., Aleardi M., et al. Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects. Am J Psychiatry 162 (2005) 1083-1089
11. DuPaul G.J., McGoey K.E., Eckert T.L., et al. Preschool children with attention-deficit/hyperactivity disorder: impairments in behavioral, social, and school functioning. J Am Acad Child Adolesc Psychiatry 40 (2001) 508-515
12. Lahey B.B., Pelham W.E., Loney J., et al. Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4-6 years of age. Am J Psychiatry 161 (2004) 2014-2020
13. Lahey B.B., Pelham W.E., Stein M.A., et al. Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. J Am Acad Child Adolesc Psychiatry 37 (1998) 695-702
14. Connor D.F., Edwards G., Fletcher K.E., et al. Correlates of comorbid psychopathology in children with ADHD. J Am Acad Child Adolesc Psychiatry 42 (2003) 193-200
15. Cunningham C.E., and Boyle M.H. Preschoolers at risk for attention-deficit hyperactivity disorder and oppositional defiant disorder: family, parenting, and behavioral correlates. J Abnorm Child Psychol 30 (2002) 555-569
16. Barkley R.A. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 3rd Edition (2006), Guilford Press, New York
17. Faraone S.V., Perlis R.H., Doyle A.E., et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1313-1323
18. Willcutt E.G., Doyle A.E., Nigg J.T., et al. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 57 (2005) 1336-1346
19. Castellanos F.X., Lee P.P., Sharp W., et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288 (2002) 1740-1748
20. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 57 (2005) 1215-1220
21. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
22. Kreppner J.M., O'Connor T.G., and Rutter M. Can inattention/overactivity be an institutional deprivation syndrome?. J Abnorm Child Psychol 29 (2001) 513-528
23. Voeller K.K. Attention-deficit hyperactivity disorder (ADHD). J Child Neurol 19 (2004) 798-814
24. Durston S., Hulshoff Pol H.E., Schnack H.G., et al. Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. J Am Acad Child Adolesc Psychiatry 43 (2004) 332-340
25. Hardy K.K., Kollins S.H., Murray D.W., et al. Factor structure of parent- and teacher-rated ADHD symptoms in preschoolers in the preschoolers with ADHD treatment study (PATS). Journal of Child and Adolescent Psychopharmacology 17 (2007) 621-634
26. Krause J., Krause K.H., Dresel S.H., et al. ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine. Dialogues Clin Neurosci 8 (2006) 29-36
27. Vaughan B.S., Wetzel M.W., and Kratochvil C.J. Beyond the "typical" patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults. Int Rev Psychiatry 20 (2008) 143-149
28. DuPaul G.J., Power T.J., Anastopoulos A.D., et al. ADHD Rating Scale-IV: checklists, norms, and clinical interpretations (1998), Guilford Press, New York, NY
29. Collett B.R., Ohan J.L., and Myers K.M. Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 42 (2003) 1015-1037
30. Madaan V., Daughton J., Lubberstedt B., et al. Assessing the efficacy of treatments for ADHD: overview of methodological issues. CNS Drugs 22 (2008) 275-290
31. Conners C.K., Sitarenios G., Parker J.D., et al. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26 (1998) 257-268
32. Conners C.K., Sitarenios G., Parker J.D., et al. Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26 (1998) 279-291
33. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46 (2007) 894-921
34. American Academy of Pediatrics: clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. J Pediatri 108 (2001) 1033-1044
35. MTA Cooperative Group: a 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. multimodal treatment study of children with ADHD. Archives of General Psychiatry 56 (1999) 1073-1086
36. Greenhill L., Kollins S., Abikoff H., et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45 (2006) 1284-1293
37. Bodenheimer T., Wagner E.H., and Grumbach K. Improving primary care for patients with chronic illness. JAMA 288 (2002) 1775-1779
38. Bodenheimer T., Wagner E.H., and Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 288 (1909) 1909-1914
39. Biederman J., and Spencer T.J. Psychopharmacological interventions. Child Adolesc Psychiatr Clin N Am 17 (2008) 439-458
40. Brown R.T., Amler R.W., Freeman W.S., et al. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics 115 (2005) e749-e757
41. Greenhill L.L., Pliszka S., Dulcan M.K., et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41 (2002) 26S-49S
42. Pliszka S.R., Liotti M., Bailey B.Y., et al. Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17 (2007) 356-366
43. Madaan V., Kinnan S., Daughton J., et al. Innovations and recent trends in the treatment of ADHD. Expert Rev Neurother 6 (2006) 1375-1385
44. Pliszka S.R., Crismon M.L., Hughes C.W., et al. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45 (2006) 642-657
45. Biederman J., Spencer T., and Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 7 (2004) 77-97
46. Faraone S. Understanding the effect size of ADHD medications: implications for clinical care. Medscape Psychiatry & Mental Health 8 (2003) 2
47. Wigal T., Greenhill L., Chuang S., et al. Safety and tolerability of methylphenidate in preschool children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 45 (2006) 1294-1303
48. Kratochvil C.J., Vaughan B.S., Mayfield-Jorgensen M.L., et al. A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17 (2007) 175-185
49. Faraone S.V., Biederman J., Morley C.P., et al. Effect of stimulants on height and weight: a review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry 47 (2008) 994-1009
50. Swanson JM, Ruff DD, Feldman PD, et al. Characterization of growth in children with ADHD. In: Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto Canada; 2005.
51. Gittelman R., Landa B., Mattes J., et al. Methylphenidate and growth in hyperactive children: a controlled withdrawal study. Archives of General Psychiatry 45 (1988) 1127-1130
52. Kaffman M., and Sher A. Bar-Sinai N: MBD children-variability in developmental patterns or growth inhibitory effects of stimulants?. Israel Annals of Psychiatry and Related Disciplines 17 (1979) 58-66
53. Klein R.G., and Mannuzza S. Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height. Arch Gen Psychiatry 45 (1988) 1131-1134
54. Safer D., Allen R., and Barr E. Growth rebound after termination of stimulant drugs. J Pediatri 86 (1975) 113-116
55. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113 (2004) 762-769
56. Spencer T.J., Newcorn J.H., Kratochvil C.J., et al. Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder. Pediatrics 116 (2005) e74-e80
57. Perrin J.M., Friedman R.A., and Knilans T.K. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics 122 (2008) 451-453
58. Connor D.F. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment. J Dev Behav Pediatr 23 (2002) S1-S9
59. Firestone P., Musten L.M., Pisterman S., et al. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 8 (1998) 13-25
60. Wigal S.B., Gupta S., Greenhill L., et al. Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17 (2007) 153-164
61. Charach A., Ickowicz A., and Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry 43 (2004) 559-567
62. Barkley R.A. Driving impairments in teens and adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 27 (2004) 233-260
63. Evans S.W., Pelham W.E., Smith B.H., et al. Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Exp Clin Psychopharmacol 9 (2001) 163-175
64. Smith B.H., Pelham W.E., Gnagy E., et al. Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence. J Am Acad Child Adolesc Psychiatry 37 (1998) 314-321
65. Wilens T.E., Kratochvil C., Newcorn J.H., et al. Do children and adolescents with ADHD respond differently to atomoxetine?. J Am Acad Child Adolesc Psychiatry 45 (2006) 149-157
66. Wilens T.E., Newcorn J.H., Kratochvil C.J., et al. Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Pediatr 149 (2006) 112-119